0820 - Sequence # 7225 and 7250 | Intraprocedure Anticoagulation & Other-0820 - Sequence # 7225 and 7250

Video Transcription

Thank you for reviewing the AFib Ablation Registry Monthly Case Scenario for August 2020.  This month's case scenario is focused on Sequence 7225, Intra-Procedure Anticoagulation, and Sequence 7250, Other.  We have documentation of a patient being admitted for an AFib Ablation procedure. When abstracting the procedure into the registry, it is noted the patient's Eloquus was not  held prior to the procedure, with the last dose of the medication being taken the morning of the procedure.  It is also documented the operating clinician was made aware of the uninterrupted Eloquus therapy prior to the start of the procedure.  Based on the documentation available, how will the uninterrupted Eloquus therapy be captured when coding the procedure's Intra-Procedure Anticoagulation strategy in Sequences 7225  to 7265?  1. Uninterrupted Warfarin therapy. 2. Other. Or 3. Bivalirudin. Please review the documentation and question to determine the best answer. We will give you a few seconds to review.  The answer is number 2, Other. If Eloquus was not held for the procedure, please code Yes to Sequence 7250, Other Anticoagulant,  as Eloquus, Apixaban, was not held for the procedure and therefore used as an anticoagulant during the procedure.  The patient's medical record will reflect that therapy with Eloquus was continued and had not been held for the procedure.  Sequence 7230, Uninterrupted Warfarin therapy, is to indicate if the patient continued on Warfarin therapy and it was not held for the procedure.  It does not apply to P2Y12 inhibitors or NOAC agents. And Sequence 7245, Bivalirudin, is to indicate if Bivalirudin was used during the procedure.  Apixaban will be coded as Current when capturing pre-procedure medications, as the medication was being taken routinely and was not held or discontinued prior to the procedure, with  the last dose taken within 24 hours from the start of the procedure. Thank you for reviewing the AFib Ablation Registry Monthly Case Scenario for August 2020.

Video Summary

In this video, the AFib Ablation Registry Monthly Case Scenario for August 2020 is discussed. The case scenario focuses on two sequences: Intra-Procedure Anticoagulation (7225) and Other (7250). A patient was admitted for an AFib Ablation procedure and it is noted that their Eloquus medication was not held prior to the procedure. The operating clinician was aware of this. Based on the available documentation, the uninterrupted Eloquus therapy should be captured using the code for Other (Sequence 7250). If Eloquus was not held, it should be coded as an anticoagulant used during the procedure. Warfarin therapy and Bivalirudin are separate codes. Apixaban is coded as Current for pre-procedure medication.

Keywords

AFib Ablation Registry

Monthly Case Scenario

August 2020

Intra-Procedure Anticoagulation

Other